U R Kleeberg - JoVE Visualize

Showing results (31-40 of 39) with videos related to

Pageof 4

Sort By:

You have reached the last page of results.This site can display upto 39 results.

Melanoma Research|September 1, 1992

Tamoxifen as a single agent for advanced melanoma in postmenopausal women. A phase II study of the EORTC Malignant Melanoma Cooperative GroupP Rümke, U R Kleeberg, R M MacKie, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 2002

Fulvestrant, formerly ICI 182,780, is as effective as anastrozole in postmenopausal women with advanced breast cancer progressing after prior endocrine treatmentA Howell, J F R Robertson, J Quaresma Albano, et al.

Melanoma Research|June 1, 1995

Palliative therapy of melanoma patients with fotemustine. Inverse relationship between tumour load and treatment effectiveness. A multicentre phase II trial of the EORTC-Melanoma Cooperative Group (MCG)U R Kleeberg, E Engel, P Israels, et al.

Seminars in Oncology|April 1, 1992

Treatment of metastatic colorectal carcinoma with a combination of fluorouracil and recombinant interferon alfa-2b: preliminary data of a phase II studyH J Weh, D Platz, D Braumann, et al.

European Journal of Cancer (Oxford, England : 1990)|January 1, 1992

Phase II trial of 5-fluorouracil and recombinant interferon alfa-2B in metastatic colorectal carcinomaH J Weh, D Platz, D Braumann, et al.

Melanoma Research|December 22, 1999

Infections and melanoma risk: results of a multicentre EORTC case-control study. European Organization for Research and Treatment of CancerK F Kölmel, A Pfahlberg, G Mastrangelo, et al.

British Journal of Cancer|October 25, 2000

High tPA-expression in primary melanoma of the limb correlates with good prognosisC M Ferrier, S Suciu, W L van Geloof, et al.

European Journal of Cancer (Oxford, England : 1990)|October 15, 2003

Impact of vaccinations and infectious diseases on the risk of melanoma--evaluation of an EORTC case-control studyB Krone, K F Kölmel, J M Grange, et al.

European Journal of Cancer (Oxford, England : 1990)|December 25, 2004

Prior immunisation of patients with malignant melanoma with vaccinia or BCG is associated with better survival. An European Organization for Research and Treatment of Cancer cohort study on 542 patientsK F Kölmel, J M Grange, B Krone, et al.

Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:

Pageof 4

You have reached the last page of results.This site can display upto 39 results.

Melanoma Research|September 1, 1992

Tamoxifen as a single agent for advanced melanoma in postmenopausal women. A phase II study of the EORTC Malignant Melanoma Cooperative GroupP Rümke, U R Kleeberg, R M MacKie, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 2002

Fulvestrant, formerly ICI 182,780, is as effective as anastrozole in postmenopausal women with advanced breast cancer progressing after prior endocrine treatmentA Howell, J F R Robertson, J Quaresma Albano, et al.

Melanoma Research|June 1, 1995

Palliative therapy of melanoma patients with fotemustine. Inverse relationship between tumour load and treatment effectiveness. A multicentre phase II trial of the EORTC-Melanoma Cooperative Group (MCG)U R Kleeberg, E Engel, P Israels, et al.

Seminars in Oncology|April 1, 1992

Treatment of metastatic colorectal carcinoma with a combination of fluorouracil and recombinant interferon alfa-2b: preliminary data of a phase II studyH J Weh, D Platz, D Braumann, et al.

European Journal of Cancer (Oxford, England : 1990)|January 1, 1992

Phase II trial of 5-fluorouracil and recombinant interferon alfa-2B in metastatic colorectal carcinomaH J Weh, D Platz, D Braumann, et al.

Melanoma Research|December 22, 1999

Infections and melanoma risk: results of a multicentre EORTC case-control study. European Organization for Research and Treatment of CancerK F Kölmel, A Pfahlberg, G Mastrangelo, et al.

British Journal of Cancer|October 25, 2000

High tPA-expression in primary melanoma of the limb correlates with good prognosisC M Ferrier, S Suciu, W L van Geloof, et al.

European Journal of Cancer (Oxford, England : 1990)|October 15, 2003

Impact of vaccinations and infectious diseases on the risk of melanoma--evaluation of an EORTC case-control studyB Krone, K F Kölmel, J M Grange, et al.

European Journal of Cancer (Oxford, England : 1990)|December 25, 2004

Prior immunisation of patients with malignant melanoma with vaccinia or BCG is associated with better survival. An European Organization for Research and Treatment of Cancer cohort study on 542 patientsK F Kölmel, J M Grange, B Krone, et al.

Pageof 4